Research Article
[Retracted] Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression
Table 2
Comparison of clinical efficacy (n (%)).
| | Conventional group (n = 40) | Experimental group (n = 40) | x2 | value |
| CR | 8 | 13 | | | PR | 11 | 20 | | | SD | 7 | 3 | | | PD | 14 | 4 | | | RR | 19 (48%) | 33 (83%) | 10.769 | 0.001 | DCR | 26 (65%) | 36 (90%) | 7.168 | 0.007 |
|
|